Kat Wendelstadt

At Praava, Kat is responsible for customer and revenue growth, spanning all channels. Her remit is driving awareness, conversion and retention effectively across all channels.

Kat is a serial health tech entrepreneur, executive, investor and leader in emerging market healthcare. She is Co-Founder of Amparo, a chain of primary care clinics across Brazil (Series B, $50m). Prior to that Kat was CMO of Dr.Consulta, Latin America’s largest chain of primary care clinics where she grew revenue and valuation 3x in 18 months. In 2015 she was one of the original co-founders of Helixnano, a Singularity University biotech startup accelerated by Y Combinator and invested in by Johnson & Johnson. Since 2014, Kat has been working to bring low cost, high quality models of care to the markets that need it most.